Answers are grounded in this paper and cite their sources.
challenge. The iVAX platform promises to accelerate development of new conjugate vaccines with increased access through refrigeration-independent distribution and portable production.
No takes yet. Share an insight, caveat, or question.
Stark et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: